Tenaya Therapeutics (TNYA) Interest & Investment Income (2020 - 2026)
Tenaya Therapeutics' quarterly Interest & Investment Income came in at $793000.0 in Q1 2026, up 24.88% year-on-year from $635000.0 in Q1 2025, and up 37.91% quarter-over-quarter from $575000.0 in Q4 2025.
Tenaya Therapeutics has reported Interest & Investment Income for 7 years, with the latest figure at $793000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 24.88% year-over-year to $793000.0; the trailing twelve-month figure through Mar 2026 stood at $2.8 million (down 27.53% YoY), and the FY2025 full-year result was $2.7 million, down 43.38% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $793000.0, up from $575000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $2.0 million in Q1 2023, with the low at $99000.0 in Q1 2022.
- Average Interest & Investment Income over 5 years is $1.0 million, with a median of $815000.0 recorded in 2025.
- Year-over-year, Interest & Investment Income jumped 2491.3% in 2022 and sank 56.27% in 2025.
- Tracing TNYA's Interest & Investment Income over 5 years: stood at $1.0 million in 2022, then soared by 41.76% to $1.5 million in 2023, then sank by 44.76% to $812000.0 in 2024, then dropped by 29.19% to $575000.0 in 2025, then surged by 37.91% to $793000.0 in 2026.
- The last three Interest & Investment Income figures came in at $793000.0 (Q1 2026), $575000.0 (Q4 2025), and $658000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Tenaya Therapeutics | 193.57 Mn | 193.57 Mn | - | 793,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 793,000.00 |
| Dec 31, 2025 | 575,000.00 |
| Sep 30, 2025 | 658,000.00 |
| Jun 30, 2025 | 815,000.00 |
| Mar 31, 2025 | 635,000.00 |
| Dec 31, 2024 | 812,000.00 |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 1.39 Mn |
| Mar 31, 2024 | 1.45 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Sep 30, 2023 | 1.78 Mn |
| Jun 30, 2023 | 1.84 Mn |
| Mar 31, 2023 | 1.97 Mn |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 596,000.00 |
| Jun 30, 2022 | 222,000.00 |
| Mar 31, 2022 | 99,000.00 |
| Dec 31, 2021 | 67,000.00 |
| Sep 30, 2021 | 23,000.00 |
| Jun 30, 2021 | 9,000.00 |
| Mar 31, 2021 | 9,000.00 |
| Dec 31, 2020 | 5,000.00 |
| Sep 30, 2020 | 7,000.00 |
| Jun 30, 2020 | 18,000.00 |